The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
The AACR has designated this live activity for a maximum of 43.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.
CLAIMING (CME) CREDIT
Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)™ for this live continuing medical education activity must complete the online CME Request for Credit Survey above by Friday, May 24. Certificates may be printed online after completing the Request for Credit Survey.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE AND LEARNING OBJECTIVES
With the accelerating pace of discoveries in the basic, translational and clinical sciences, due in large part to the advent of new technologies, cancer researchers are making rapid progress that is having significant patient benefit. By bridging the gap between what physicians understand about cancer biology and the clinical applications, this meeting aids basic researchers, physicians and clinician-scientists in obtaining, synthesizing and integrating the most cutting-edge research. This exposure is essential for the implementation of best practices, such as the most current molecular-based tests to aid in the diagnosis, treatment and prevention of cancer. Further, facilitating the interface between physicians and scientists will increase knowledge of the epidemiological implications of cancer incidence and the contributions of laboratory research to drug development as well as patient care; transform the design and conduct of clinical research protocols; and create a forum for the rapid translation of laboratory research findings from “bench-to-bedside” for the benefit of improving patient outcomes.
After participating in this CME activity, participants will be able to:
- Apply technological advances to accelerate progress in cancer research and improve early detection, and early intervention, with the ultimate goal of extending patients’ lives and improving their quality of life;
- Explain the integration of information from basic and translational sciences to drug development, clinical research and application of new findings;
- Improve patient selection (or stratification) for clinical trials through the use of biomarkers and other indicators;
- Incorporate the latest research findings regarding therapies and treatment options in a variety of cancer types in order to improve patient outcomes;
- Formulate new strategies that will further scientific and clinical research efforts towards the prevention and early detection of cancer; and
- Develop collaborations among physicians, researchers and clinician-scientists to advance the cause of treating and preventing cancer.
It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the Program/Proceedings of this conference and is available for download.
ACKNOWLEDGEMENT OF FINANCIAL OR OTHER SUPPORT
This activity is supported by grants and will be disclosed at the activity.
QUESTIONS ABOUT CME?
Please contact the Office of CME at firstname.lastname@example.org or while at the Annual Meeting, visit the CME Desk in the Registration Area.